Lessons learned from COVID-19 vaccines could advance synthetic biology. Here's how
Intellectual property waivers for COVID-19 vaccines could change the course of synthetic biology, enabling the democratic distribution of technologies.
Keolu Fox is a Kānaka Maoli (Native Hawaiian) Assistant Professor at the University of California, San Diego where he is affiliated with the Department of Anthropology, the Global Health Program, the Halıcıoğlu Data Science Institute, the Climate Action Lab, and the Indigenous Futures Lab. His research interests include genome sequencing technology, genome engineering, point-of-care technology development and Indigenizing biomedical research.